High-dose intravenous immunoglobulin therapy was administered to all patients and may have contributed to neutralization of eculizumab.
Rheumatological disorders were associated with a 7-fold risk of developing Guillain-Barré syndrome.
Infection with the Zika virus may increase the risk for development of Guillain-Barré syndrome.
Patients with cancer or an autoimmune disease who underwent surgery were at a greater risk.
Anti-GalC IgG may contribute to the pathogenesis of Guillain-Barré syndrome.
The CDC recently confirmed the link between Zika virus and microcephaly.
It's unclear whether the effect that the vaccine has on contracting influenza is responsible for the reduced risk.
Neurology Advisor Articles
- Addressing Rare Headache Disorders: Acute Confusional Migraine
- Organic Solvents Plus Genetics May Increase Risk of Multiple Sclerosis
- No Significant Clinical Differences Between Cluster Headaches With and Without Aura
- Co-Prescription of Opioids and Antidepressants Prevalent in Migraine
- Deep Brain Stimulation May Slow Rest Tremor Progression in Parkinson Disease
- Herpesvirus Abundant in Alzheimer Disease Brain, New Study Finds
- Patients' Preferences for Physician Attire Linked to Perception of Care
- Weighing the Risks of Deep Brain Stimulation
- Grey Matter Atrophy Sequence in Multiple Sclerosis Phenotypes
- Higher Vitamin D Levels Associated With Fewer Lesions in Multiple Sclerosis
- Screening Tool Differentiates Progressive Supranuclear Palsy and Parkinson Disease
- Risk Factors for Impulse Control Behaviors in Parkinson Disease
- Cardiac Pathology in SUDEP Compared With Sudden Arrhythmic or Traumatic Deaths
- 11.2% of U.S. Adults Aged ≥45 Report Subjective Mental Decline
- AMA Aims to Boost Affordability of ACA Marketplace Plans